0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > BTLA

BTLA

Brief Information

Name:B- and T-lymphocyte attenuator
Target Synonym:B- and T-lymphocyte attenuator,B- and T-lymphocyte-associated protein,B And T Lymphocyte Associated,CD272 Antigen,BTLA1,CD272,BTLA
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:1
Lastest Research Phase:Phase 1 Clinical

Product ListCompare or Buy

Part of Bioactivity data

BTA-H82E6-ELISA
Biotinylated Human BTLA (31-150), His,AvitagBiotinylated Human BTLA (31-150), His,Avitag (Cat. No. BTA-H82E6) ELISA bioactivity

Immobilized Human HVEM, Mouse IgG2a Fc Tag, low endotoxin (Cat. No. HVM-H5255) at 5 μg/mL (100 μL/well) can bind Biotinylated Human BTLA (31-150), His,Avitag (Cat. No. BTA-H82E6) with a linear range of 0.156-2.5 μg/mL (QC tested).

BTA-H5258-ELISA
Human BTLA (31-150), Mouse IgG2a Fc TagHuman BTLA (31-150), Mouse IgG2a Fc Tag (Cat. No. BTA-H5258) ELISA bioactivity

Immobilized Human HVEM, His Tag (Cat. No. HVM-H52E9) at 5 μg/mL (100 μL/well) can bind Human BTLA (31-150), Mouse IgG2a Fc Tag (Cat. No. BTA-H5258) with a linear range of 10-156 ng/mL (QC tested).

Synonym Name

BTLA,CD272

Background

B- and T-lymphocyte attenuator (BTLA) is also known as B- and T-lymphocyte-associated protein, CD antigen CD272. BTLA contains one Ig-like V-type (immunoglobulin-like) domain. As a lymphocyte inhibitory receptor, BTLA / CD272 inhibits lymphocytes during immune response. BTLA / CD272 can interact with tyrosine phosphatases PTPN6/SHP-1 and PTPN11/SHP-2, and interact with TNFRSF14/HVEM.

Clinical and Translational Updates

Related Molecule

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
JS004 JS-004; TAB-004 Phase 1 Clinical Shanghai Junshi Biosciences Co Ltd Solid tumours; Head and Neck Neoplasms; Carcinoma, Renal Cell; Carcinoma, Transitional Cell; Lymphoma; Melanoma Details

This web search service is supported by Google Inc.

totop